CN110693931A - Formula and preparation method of health-preserving burdock chewable tablet - Google Patents
Formula and preparation method of health-preserving burdock chewable tablet Download PDFInfo
- Publication number
- CN110693931A CN110693931A CN201911036751.8A CN201911036751A CN110693931A CN 110693931 A CN110693931 A CN 110693931A CN 201911036751 A CN201911036751 A CN 201911036751A CN 110693931 A CN110693931 A CN 110693931A
- Authority
- CN
- China
- Prior art keywords
- parts
- burdock
- extract
- slices
- peptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000003130 Arctium lappa Nutrition 0.000 title claims abstract description 151
- 235000008078 Arctium minus Nutrition 0.000 title claims abstract description 151
- 239000007910 chewable tablet Substances 0.000 title claims abstract description 35
- 229940068682 chewable tablet Drugs 0.000 title claims abstract description 33
- 238000002360 preparation method Methods 0.000 title claims abstract description 13
- 240000005528 Arctium lappa Species 0.000 title claims description 144
- 238000009472 formulation Methods 0.000 title claims description 6
- 239000000284 extract Substances 0.000 claims abstract description 104
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 50
- 239000000843 powder Substances 0.000 claims abstract description 49
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 claims abstract description 32
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims abstract description 30
- UCMIRNVEIXFBKS-UHFFFAOYSA-N beta-alanine Chemical compound NCCC(O)=O UCMIRNVEIXFBKS-UHFFFAOYSA-N 0.000 claims abstract description 30
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 25
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 25
- 235000008434 ginseng Nutrition 0.000 claims abstract description 25
- 240000000249 Morus alba Species 0.000 claims abstract description 22
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 22
- 244000183278 Nephelium litchi Species 0.000 claims abstract description 21
- 241000237502 Ostreidae Species 0.000 claims abstract description 20
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 claims abstract description 20
- 229940107187 fructooligosaccharide Drugs 0.000 claims abstract description 20
- 235000020636 oyster Nutrition 0.000 claims abstract description 20
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 18
- 229930003231 vitamin Natural products 0.000 claims abstract description 18
- 235000013343 vitamin Nutrition 0.000 claims abstract description 18
- 239000011782 vitamin Substances 0.000 claims abstract description 18
- 229940088594 vitamin Drugs 0.000 claims abstract description 18
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 claims abstract description 17
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 claims abstract description 17
- 239000004473 Threonine Substances 0.000 claims abstract description 17
- 229940010454 licorice Drugs 0.000 claims abstract description 17
- 239000007788 liquid Substances 0.000 claims abstract description 17
- 239000002994 raw material Substances 0.000 claims abstract description 17
- 229960002898 threonine Drugs 0.000 claims abstract description 17
- 241000255789 Bombyx mori Species 0.000 claims abstract description 16
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims abstract description 15
- 239000004471 Glycine Substances 0.000 claims abstract description 15
- 229940000635 beta-alanine Drugs 0.000 claims abstract description 15
- 235000013922 glutamic acid Nutrition 0.000 claims abstract description 15
- 239000004220 glutamic acid Substances 0.000 claims abstract description 15
- DLRVVLDZNNYCBX-RTPHMHGBSA-N isomaltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-RTPHMHGBSA-N 0.000 claims abstract description 15
- 239000000845 maltitol Substances 0.000 claims abstract description 15
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 claims abstract description 15
- 235000010449 maltitol Nutrition 0.000 claims abstract description 15
- 229940035436 maltitol Drugs 0.000 claims abstract description 15
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 claims abstract description 14
- 229930064664 L-arginine Natural products 0.000 claims abstract description 14
- 235000014852 L-arginine Nutrition 0.000 claims abstract description 14
- 150000003722 vitamin derivatives Chemical class 0.000 claims abstract description 10
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims abstract description 7
- 229960002989 glutamic acid Drugs 0.000 claims abstract description 7
- 229960002449 glycine Drugs 0.000 claims abstract description 7
- 230000036541 health Effects 0.000 claims abstract description 6
- 240000004670 Glycyrrhiza echinata Species 0.000 claims abstract 4
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 42
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 37
- 241001076416 Dendrobium tosaense Species 0.000 claims description 30
- 240000004371 Panax ginseng Species 0.000 claims description 24
- 240000006108 Allium ampeloprasum Species 0.000 claims description 19
- 235000005254 Allium ampeloprasum Nutrition 0.000 claims description 19
- 239000003826 tablet Substances 0.000 claims description 18
- 235000002722 Dioscorea batatas Nutrition 0.000 claims description 17
- 240000001811 Dioscorea oppositifolia Species 0.000 claims description 17
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 claims description 17
- 241000251511 Holothuroidea Species 0.000 claims description 17
- 235000006536 Dioscorea esculenta Nutrition 0.000 claims description 15
- 244000241838 Lycium barbarum Species 0.000 claims description 14
- 235000015459 Lycium barbarum Nutrition 0.000 claims description 14
- 235000015468 Lycium chinense Nutrition 0.000 claims description 13
- 238000001816 cooling Methods 0.000 claims description 11
- 102000004190 Enzymes Human genes 0.000 claims description 10
- 108090000790 Enzymes Proteins 0.000 claims description 10
- 239000002245 particle Substances 0.000 claims description 10
- 239000000203 mixture Substances 0.000 claims description 9
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 8
- 235000017784 Mespilus germanica Nutrition 0.000 claims description 8
- 235000000560 Mimusops elengi Nutrition 0.000 claims description 8
- 235000007837 Vangueria infausta Nutrition 0.000 claims description 8
- 238000006243 chemical reaction Methods 0.000 claims description 8
- 238000004140 cleaning Methods 0.000 claims description 7
- 239000000654 additive Substances 0.000 claims description 5
- 150000001875 compounds Chemical class 0.000 claims description 5
- 238000005520 cutting process Methods 0.000 claims description 5
- 238000001035 drying Methods 0.000 claims description 5
- 238000000855 fermentation Methods 0.000 claims description 5
- 230000004151 fermentation Effects 0.000 claims description 5
- 239000008187 granular material Substances 0.000 claims description 5
- 230000001788 irregular Effects 0.000 claims description 5
- 238000004806 packaging method and process Methods 0.000 claims description 5
- 238000009928 pasteurization Methods 0.000 claims description 5
- 238000003825 pressing Methods 0.000 claims description 5
- 238000005057 refrigeration Methods 0.000 claims description 5
- 238000007873 sieving Methods 0.000 claims description 5
- 238000002791 soaking Methods 0.000 claims description 5
- 238000003860 storage Methods 0.000 claims description 5
- 238000005406 washing Methods 0.000 claims description 5
- 238000005303 weighing Methods 0.000 claims description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 4
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 4
- 229930003270 Vitamin B Natural products 0.000 claims description 4
- 229930003268 Vitamin C Natural products 0.000 claims description 4
- 239000004576 sand Substances 0.000 claims description 4
- 235000019156 vitamin B Nutrition 0.000 claims description 4
- 239000011720 vitamin B Substances 0.000 claims description 4
- 235000019154 vitamin C Nutrition 0.000 claims description 4
- 239000011718 vitamin C Substances 0.000 claims description 4
- 229930003427 Vitamin E Natural products 0.000 claims description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 2
- 235000019165 vitamin E Nutrition 0.000 claims description 2
- 229940046009 vitamin E Drugs 0.000 claims description 2
- 239000011709 vitamin E Substances 0.000 claims description 2
- 244000182216 Mimusops elengi Species 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 239000000126 substance Substances 0.000 abstract description 13
- 241000382353 Pupa Species 0.000 abstract description 7
- 230000001965 increasing effect Effects 0.000 abstract description 7
- 235000015097 nutrients Nutrition 0.000 abstract description 7
- 235000019640 taste Nutrition 0.000 abstract description 5
- XOJVHLIYNSOZOO-SWOBOCGESA-N Arctiin Chemical compound C1=C(OC)C(OC)=CC=C1C[C@@H]1[C@@H](CC=2C=C(OC)C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)=CC=2)C(=O)OC1 XOJVHLIYNSOZOO-SWOBOCGESA-N 0.000 abstract description 3
- 239000000463 material Substances 0.000 abstract description 2
- 241000208843 Arctium Species 0.000 abstract 7
- AYRXSINWFIIFAE-SCLMCMATSA-N Isomaltose Natural products OC[C@H]1O[C@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)[C@@H](O)[C@@H](O)[C@@H]1O AYRXSINWFIIFAE-SCLMCMATSA-N 0.000 abstract 2
- 241000965254 Apostichopus japonicus Species 0.000 abstract 1
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 27
- 210000004369 blood Anatomy 0.000 description 20
- 239000008280 blood Substances 0.000 description 20
- 239000003814 drug Substances 0.000 description 16
- 230000006870 function Effects 0.000 description 16
- 230000003405 preventing effect Effects 0.000 description 13
- 230000001737 promoting effect Effects 0.000 description 13
- 241000202807 Glycyrrhiza Species 0.000 description 12
- 230000009286 beneficial effect Effects 0.000 description 9
- 230000036039 immunity Effects 0.000 description 9
- 210000003734 kidney Anatomy 0.000 description 9
- 210000000952 spleen Anatomy 0.000 description 9
- 229920002472 Starch Polymers 0.000 description 8
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 8
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 8
- 230000002708 enhancing effect Effects 0.000 description 8
- 210000004185 liver Anatomy 0.000 description 8
- 235000019698 starch Nutrition 0.000 description 8
- 239000008107 starch Substances 0.000 description 8
- 210000002784 stomach Anatomy 0.000 description 8
- 206010011224 Cough Diseases 0.000 description 7
- 240000002624 Mespilus germanica Species 0.000 description 7
- 235000019197 fats Nutrition 0.000 description 7
- 210000004072 lung Anatomy 0.000 description 7
- 235000016709 nutrition Nutrition 0.000 description 7
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 6
- 150000001720 carbohydrates Chemical class 0.000 description 6
- 206010012601 diabetes mellitus Diseases 0.000 description 6
- 239000000835 fiber Substances 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 5
- 206010010774 Constipation Diseases 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 239000011575 calcium Substances 0.000 description 5
- 229910052791 calcium Inorganic materials 0.000 description 5
- 230000029087 digestion Effects 0.000 description 5
- 206010016256 fatigue Diseases 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 230000012010 growth Effects 0.000 description 5
- 230000002401 inhibitory effect Effects 0.000 description 5
- 230000000144 pharmacologic effect Effects 0.000 description 5
- 230000002829 reductive effect Effects 0.000 description 5
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 4
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 201000011510 cancer Diseases 0.000 description 4
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 4
- 229940090949 docosahexaenoic acid Drugs 0.000 description 4
- 235000013399 edible fruits Nutrition 0.000 description 4
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 4
- 229960005135 eicosapentaenoic acid Drugs 0.000 description 4
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 4
- 230000004438 eyesight Effects 0.000 description 4
- 210000001035 gastrointestinal tract Anatomy 0.000 description 4
- 230000006872 improvement Effects 0.000 description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- 239000011259 mixed solution Substances 0.000 description 4
- 230000035764 nutrition Effects 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 239000000341 volatile oil Substances 0.000 description 4
- 208000024172 Cardiovascular disease Diseases 0.000 description 3
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 3
- 229910021529 ammonia Inorganic materials 0.000 description 3
- 230000036528 appetite Effects 0.000 description 3
- 235000019789 appetite Nutrition 0.000 description 3
- 206010003549 asthenia Diseases 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 210000000232 gallbladder Anatomy 0.000 description 3
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 3
- 230000036737 immune function Effects 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 239000011574 phosphorus Substances 0.000 description 3
- 229910052698 phosphorus Inorganic materials 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- 239000003053 toxin Substances 0.000 description 3
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 3
- WRGQSWVCFNIUNZ-GDCKJWNLSA-N 1-oleoyl-sn-glycerol 3-phosphate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)COP(O)(O)=O WRGQSWVCFNIUNZ-GDCKJWNLSA-N 0.000 description 2
- 206010002660 Anoxia Diseases 0.000 description 2
- 241000976983 Anoxia Species 0.000 description 2
- 239000004475 Arginine Substances 0.000 description 2
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 2
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 244000281702 Dioscorea villosa Species 0.000 description 2
- 208000010228 Erectile Dysfunction Diseases 0.000 description 2
- 208000007882 Gastritis Diseases 0.000 description 2
- 244000303040 Glycyrrhiza glabra Species 0.000 description 2
- 239000004378 Glycyrrhizin Substances 0.000 description 2
- 241000590002 Helicobacter pylori Species 0.000 description 2
- 208000031226 Hyperlipidaemia Diseases 0.000 description 2
- 206010021143 Hypoxia Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- 208000005016 Intestinal Neoplasms Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 206010067171 Regurgitation Diseases 0.000 description 2
- 208000006011 Stroke Diseases 0.000 description 2
- UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 description 2
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 2
- 208000007536 Thrombosis Diseases 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- AWUCVROLDVIAJX-UHFFFAOYSA-N alpha-glycerophosphate Natural products OCC(O)COP(O)(O)=O AWUCVROLDVIAJX-UHFFFAOYSA-N 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000007953 anoxia Effects 0.000 description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 2
- 235000009697 arginine Nutrition 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 235000015872 dietary supplement Nutrition 0.000 description 2
- 235000004879 dioscorea Nutrition 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 235000003599 food sweetener Nutrition 0.000 description 2
- 208000020694 gallbladder disease Diseases 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 2
- 229960004949 glycyrrhizic acid Drugs 0.000 description 2
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 2
- 235000019410 glycyrrhizin Nutrition 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- 229940037467 helicobacter pylori Drugs 0.000 description 2
- 201000001881 impotence Diseases 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- 201000002313 intestinal cancer Diseases 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 208000019423 liver disease Diseases 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 229960003512 nicotinic acid Drugs 0.000 description 2
- 235000001968 nicotinic acid Nutrition 0.000 description 2
- 239000011664 nicotinic acid Substances 0.000 description 2
- 235000019161 pantothenic acid Nutrition 0.000 description 2
- 229940055726 pantothenic acid Drugs 0.000 description 2
- 239000011713 pantothenic acid Substances 0.000 description 2
- 230000036961 partial effect Effects 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 150000003904 phospholipids Chemical class 0.000 description 2
- 235000019633 pungent taste Nutrition 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 239000005871 repellent Substances 0.000 description 2
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 230000001502 supplementing effect Effects 0.000 description 2
- 239000003765 sweetening agent Substances 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 2
- 208000004371 toothache Diseases 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 description 2
- 210000004881 tumor cell Anatomy 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- CWVRJTMFETXNAD-BMNNCGMMSA-N (1s,3r,4s,5r)-3-[(e)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy-1,4,5-trihydroxycyclohexane-1-carboxylic acid Chemical compound O[C@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-BMNNCGMMSA-N 0.000 description 1
- DSLBDPPHINVUID-REOHCLBHSA-N (2s)-2-aminobutanediamide Chemical compound NC(=O)[C@@H](N)CC(N)=O DSLBDPPHINVUID-REOHCLBHSA-N 0.000 description 1
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 208000000044 Amnesia Diseases 0.000 description 1
- 208000031091 Amnestic disease Diseases 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 241000208838 Asteraceae Species 0.000 description 1
- 208000004300 Atrophic Gastritis Diseases 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- QRYRORQUOLYVBU-VBKZILBWSA-N Carnosic acid Natural products CC([C@@H]1CC2)(C)CCC[C@]1(C(O)=O)C1=C2C=C(C(C)C)C(O)=C1O QRYRORQUOLYVBU-VBKZILBWSA-N 0.000 description 1
- 108010087806 Carnosine Proteins 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- 102000030523 Catechol oxidase Human genes 0.000 description 1
- 108010031396 Catechol oxidase Proteins 0.000 description 1
- 206010065559 Cerebral arteriosclerosis Diseases 0.000 description 1
- 206010008132 Cerebral thrombosis Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 241000220485 Fabaceae Species 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 208000036495 Gastritis atrophic Diseases 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- GLLUYNRFPAMGQR-UHFFFAOYSA-N Glycyphyllin Natural products OC1C(O)C(O)C(C)OC1OC1=CC(O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 GLLUYNRFPAMGQR-UHFFFAOYSA-N 0.000 description 1
- 240000008917 Glycyrrhiza uralensis Species 0.000 description 1
- 235000000554 Glycyrrhiza uralensis Nutrition 0.000 description 1
- 102000018997 Growth Hormone Human genes 0.000 description 1
- 108010051696 Growth Hormone Proteins 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010062767 Hypophysitis Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- 102000007330 LDL Lipoproteins Human genes 0.000 description 1
- 108010007622 LDL Lipoproteins Proteins 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 229930194248 Licoflavone Natural products 0.000 description 1
- MEHHCBRCXIDGKZ-UHFFFAOYSA-N Licoflavone C Natural products CC(C)=CCC1=C(O)C=C(O)C(C(C=2)=O)=C1OC=2C1=CC=C(O)C=C1 MEHHCBRCXIDGKZ-UHFFFAOYSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- NTNWOCRCBQPEKQ-YFKPBYRVSA-N N(omega)-methyl-L-arginine Chemical group CN=C(N)NCCC[C@H](N)C(O)=O NTNWOCRCBQPEKQ-YFKPBYRVSA-N 0.000 description 1
- CQOVPNPJLQNMDC-UHFFFAOYSA-N N-beta-alanyl-L-histidine Natural products NCCC(=O)NC(C(O)=O)CC1=CN=CN1 CQOVPNPJLQNMDC-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- 235000015742 Nephelium litchi Nutrition 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 1
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 208000015634 Rectal Neoplasms Diseases 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 206010041497 Spermatorrhoea Diseases 0.000 description 1
- 208000019229 Spleen disease Diseases 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 206010042682 Swelling face Diseases 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 102000003425 Tyrosinase Human genes 0.000 description 1
- 108060008724 Tyrosinase Proteins 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 206010047623 Vitamin C deficiency Diseases 0.000 description 1
- 208000031975 Yang Deficiency Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000006986 amnesia Effects 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- BPYGTFFYYOWDBC-LOVSFRALSA-N arctiin Natural products COc1ccc(C[C@H]2COC(=O)[C@@H]2Cc3ccc(O[C@@H]4O[C@H](C)[C@@H](O)[C@H](O)[C@H]4O)c(OC)c3)cc1OC BPYGTFFYYOWDBC-LOVSFRALSA-N 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- IPOKCKJONYRRHP-FMQUCBEESA-N balsalazide Chemical compound C1=CC(C(=O)NCCC(=O)O)=CC=C1\N=N\C1=CC=C(O)C(C(O)=O)=C1 IPOKCKJONYRRHP-FMQUCBEESA-N 0.000 description 1
- 229960004168 balsalazide Drugs 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 235000004883 caffeic acid Nutrition 0.000 description 1
- 229940074360 caffeic acid Drugs 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 229940044199 carnosine Drugs 0.000 description 1
- CQOVPNPJLQNMDC-ZETCQYMHSA-N carnosine Chemical compound [NH3+]CCC(=O)N[C@H](C([O-])=O)CC1=CNC=N1 CQOVPNPJLQNMDC-ZETCQYMHSA-N 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- 201000001352 cholecystitis Diseases 0.000 description 1
- 208000016644 chronic atrophic gastritis Diseases 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 239000000490 cosmetic additive Substances 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000009849 deactivation Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- CEYUIFJWVHOCPP-UHFFFAOYSA-L disodium;(3-amino-1-hydroxy-1-phosphonatopropyl)phosphonic acid Chemical compound [Na+].[Na+].NCCC(O)(P(O)([O-])=O)P(O)([O-])=O CEYUIFJWVHOCPP-UHFFFAOYSA-L 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 208000000718 duodenal ulcer Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 230000000235 effect on cancer Effects 0.000 description 1
- 230000000225 effect on diabetes Effects 0.000 description 1
- 230000009982 effect on human Effects 0.000 description 1
- 239000002158 endotoxin Substances 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 201000005577 familial hyperlipidemia Diseases 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 229960002737 fructose Drugs 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 208000001130 gallstones Diseases 0.000 description 1
- 230000007661 gastrointestinal function Effects 0.000 description 1
- 230000005176 gastrointestinal motility Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229960001031 glucose Drugs 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- GLLUYNRFPAMGQR-PPNXFBDMSA-N glycyphyllin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC1=CC(O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 GLLUYNRFPAMGQR-PPNXFBDMSA-N 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 239000000122 growth hormone Substances 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000000415 inactivating effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 201000005851 intracranial arteriosclerosis Diseases 0.000 description 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- KRZBCHWVBQOTNZ-DLDRDHNVSA-N isochlorogenic acid Natural products O[C@@H]1[C@H](C[C@@](O)(C[C@H]1OC(=O)C=Cc2ccc(O)c(O)c2)C(=O)O)OC(=O)C=Cc3ccc(O)c(O)c3 KRZBCHWVBQOTNZ-DLDRDHNVSA-N 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 235000011477 liquorice Nutrition 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000001050 lubricating effect Effects 0.000 description 1
- 239000008518 lycium barbarum polysaccharide Substances 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 235000015816 nutrient absorption Nutrition 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 150000002482 oligosaccharides Polymers 0.000 description 1
- 229960003104 ornithine Drugs 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229960000292 pectin Drugs 0.000 description 1
- 235000019477 peppermint oil Nutrition 0.000 description 1
- 238000005502 peroxidation Methods 0.000 description 1
- 230000001817 pituitary effect Effects 0.000 description 1
- 210000003635 pituitary gland Anatomy 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 229920001197 polyacetylene Polymers 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 206010036596 premature ejaculation Diseases 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 206010038038 rectal cancer Diseases 0.000 description 1
- 201000001275 rectum cancer Diseases 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 208000010233 scurvy Diseases 0.000 description 1
- 201000008525 senile cataract Diseases 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 230000019100 sperm motility Effects 0.000 description 1
- 230000021595 spermatogenesis Effects 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 208000027140 splenic disease Diseases 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 208000018556 stomach disease Diseases 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 229960004793 sucrose Drugs 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- -1 sulfur alkynes Chemical class 0.000 description 1
- 230000009747 swallowing Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- DSNBHJFQCNUKMA-SCKDECHMSA-N thromboxane A2 Chemical compound OC(=O)CCC\C=C/C[C@@H]1[C@@H](/C=C/[C@@H](O)CCCCC)O[C@@H]2O[C@H]1C2 DSNBHJFQCNUKMA-SCKDECHMSA-N 0.000 description 1
- 230000003867 tiredness Effects 0.000 description 1
- 208000016255 tiredness Diseases 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7032—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a polyol, i.e. compounds having two or more free or esterified hydroxy groups, including the hydroxy group involved in the glycosidic linkage, e.g. monoglucosyldiacylglycerides, lactobionic acid, gangliosides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/77—Sapindaceae (Soapberry family), e.g. lychee or soapberry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8962—Allium, e.g. garden onion, leek, garlic or chives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8969—Polygonatum (Solomon's seal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
- A61K36/8984—Dendrobium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
- A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/19—Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Diabetes (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Physiology (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
A health burdock chewable tablet formula and its preparation method, regard radix Arctii as the main material, it is rich in ginseng powder, oyster peptide, rhizoma Polygonati powder, licorice powder, Stichopus japonicus peptide, silkworm pupa peptide, litchi extract, rhizoma Dioscoreae, fructus Lycii extract, folium Allii tuberosi extract, mulberry extract, herba Dendrobii extract, fructo-oligosaccharide, oligomeric isomaltose, maltitol, L-arginine, glycine, glutamic acid, L-threonine, beta-alanine, vitamin, make burdock chewable tablet; according to the invention, the frozen burdock roots are cleaned, peeled, sliced, color-protected, enzyme-deactivated and cooled, and then mixed liquid of fructo-oligosaccharide, isomaltose hypgather and maltitol is added, so that the burdock slices fully absorb nutrient liquid raw materials to fill gaps of the burdock, the nutrient components of the burdock slices are higher, the absorptivity of the burdock is greatly increased, the prepared chewable tablets have good taste, can be eaten by a large number of people for a long time, and can provide various nutrient substances lacking in human bodies.
Description
Technical Field
The invention relates to a burdock chewable tablet, in particular to a formula of a health-preserving burdock chewable tablet and a preparation method thereof, and belongs to the technical field of food processing.
Background
The burdock is a 2-3 year old herbaceous plant of the compositae, has a long planting history in China, has a large amount of plants in Jiangsu and Shandong, is used as a special agricultural and sideline product, and is exported to Japan, Korea and southeast. The burdock fleshy root has bitter and pungent taste and special flavor, contains a plurality of nutrient substances necessary for human body, and each hundred grams of fresh root contains 4.70g of protein, 0.80g of fat, 3g of carbohydrate, 2.40g of crude fiber, 2.40g of ash, 0.02mg of vitamin Bl, 22.29mg of vitamin B, 1.10mg of nicotinic acid, 25.00mg of vitamin C, 242.00mg of calcium, 61.00mg of phosphorus and 7.60mg of iron, and also contains arctone, alcohol, chlorogenic acid, isochlorogenic acid, caffeic acid and derivatives thereof and the like.
However, at present, burdock root is used as a burdock beverage, burdock sugar and a burdock can for eating, and burdock root is not prepared into a chewable tablet for eating, the chewable tablet is a tablet which is chewed or sucked in the oral cavity to be dissolved and then swallowed, sweetening agents such as cane sugar and peppermint oil and edible spices are often added to adjust the taste, the surface area of the tablet is increased after the tablet is chewed, the dissolution and absorption of the medicine in the body can be promoted, the chewable tablet is particularly suitable for old people, children, stroke patients and patients with difficulty in swallowing and poor gastrointestinal function, and the burden of the medicine on the gastrointestinal tract can be reduced. Recorded in compendium of materia medica, the burdock root has the efficacies of dispelling wind heat, eliminating swelling and toxin, treating dizziness, sore throat, toothache, cough and the like. The radix Arctii also has effects of lowering blood sugar, lowering blood pressure, eliminating constipation, preventing rectal cancer, relieving inflammation, stopping bleeding, and enhancing immunity. Therefore, the application of the burdock root as the chewable tablet for human body is a new breakthrough of the burdock product.
Disclosure of Invention
Aiming at the problems in the prior art, the invention provides a formula of health-preserving burdock chewable tablet and a preparation method thereof, the preparation method is simple, burdock root is used as a main raw material to prepare the burdock chewable tablet, and the prepared burdock chewable tablet has good taste, can be eaten by a large number of people and can provide various substances lacking in human body.
In order to achieve the purpose, the invention adopts the technical scheme that: the formula of the health-preserving burdock chewable tablet is prepared from the following raw materials in parts by mass: 30-40 parts of burdock root, 10-20 parts of ginseng powder, 5-10 parts of oyster peptide, 5-10 parts of rhizoma polygonati powder, 4-6 parts of licorice powder, 2-4 parts of sea cucumber peptide, 2-4 parts of silkworm chrysalis peptide, 2-3 parts of litchi extract, 3-5 parts of Chinese yam, 2-3 parts of wolfberry extract, 2-3 parts of leek extract, 2-3 parts of mulberry extract, 2-3 parts of dendrobium officinale extract, 2-3 parts of fructo-oligosaccharide, 2-3 parts of isomalto-oligosaccharide, 2-3 parts of maltitol, 1-2 parts of L-arginine, 1-2 parts of glycine, 1-2 parts of glutamic acid, 1-2 parts of L-threonine, 1-2 parts of beta-alanine and 2-3 parts of vitamin.
Preferably, the chewable tablet is prepared from the following raw materials in parts by mass: 35 parts of burdock root, 15 parts of ginseng powder, 7.5 parts of oyster peptide, 7.5 parts of sealwort powder, 5 parts of licorice powder, 3 parts of sea cucumber peptide, 3 parts of silkworm chrysalis peptide, 2.5 parts of litchi extract, 4 parts of Chinese yam, 2.5 parts of medlar extract, 2.5 parts of leek extract, 2.5 parts of mulberry extract, 2.5 parts of dendrobium officinale extract, 2.5 parts of fructo-oligosaccharide, 2.5 parts of isomaltooligosaccharide, 2.5 parts of maltitol, 1.5 parts of L-arginine, 1.5 parts of glycine, 1.5 parts of glutamic acid, 1.5 parts of L-threonine, 1.5 parts of beta-alanine and 2.5 parts of vitamin.
As a further improvement of the invention, the vitamin is vitamin B, vitamin C or vitamin E.
A preparation method of a health-preserving burdock chewable tablet formula comprises the following steps:
s1, putting the burdock roots in a low-temperature refrigeration house for storage for 3-6 months before use for fermentation treatment; converting starch in the burdock root into a saccharide substance;
s2, selecting: removing rotten and atrophic burdock roots;
s3, cleaning: washing the burdock roots with clear water;
s4, peeling: peeling burdock root;
s5, slicing and color protection: cutting the burdock roots into slices with the thickness of 2.5-3 mm on a slicing machine, and protecting the color by using 3 per mill of citric acid color protection liquid, wherein the color protection liquid can cover the burdock slices as a standard; the citric acid is properly supplemented along with the increase of the water amount in the pool because the slicing machine needs water flow assistance);
s6, deactivating enzyme and cooling: firstly, adding 3 per mill of citric acid into a water-removing pool, removing the water of the burdock slices subjected to color protection for 2-3 min by using clear water at the temperature of 100 ℃, inactivating an enzyme system to soften fiber and convert part of starch in the burdock slices into alpha, and quickly cooling in a compound color-protecting liquid for 30min after water removal;
s7, draining, and picking: draining the cooled burdock slices, pouring the cooled burdock slices on a selecting table, and selecting large, irregular and foreign matters;
s8, weighing ginseng powder, oyster peptide, rhizoma polygonati powder, licorice powder, sea cucumber peptide, silkworm pupa peptide, litchi extract, Chinese yam, wolfberry fruit extract, leek extract, mulberry extract, dendrobium officinale extract, L-arginine, glycine, glutamic acid, L-threonine, beta-alanine, vitamins, additives and the burdock slices in the step S7 according to the proportion respectively, soaking the burdock slices in fructo-oligosaccharide, isomalto-oligosaccharide and maltitol for more than 48 hours to ensure that the burdock slices fully absorb the litchi extract, wolfberry fruit extract, leek extract, mulberry extract, dendrobium officinale extract and other raw materials to fill burdock gaps, so that the nutrition components of the burdock slices are higher, then baking at 80 ℃ to volatilize water, and the burdock slices are not sand-repellent and sugar-repellent;
s9, granulating and tabletting: after the mixture in the S8 is sieved by a 20-mesh sieve, drying and sieving particles to ensure that the water content of the particles is less than 5%; pressing the granules into tablets, and packaging the tablets after pasteurization to obtain the finished burdock agglomerant tablets.
As a further improvement of the invention, the peeling in the step S4 is performed by manual peeling or mechanical peeling.
As a further improvement of the invention, in order to ensure that the water-removing is 'thorough and not rotten', the weight of the burdock slices in the water-removing pool is not too large, and is preferably 0.8-1.2 kg.
As a further improvement of the invention, the low-temperature environment in the step S1 is 2-8 ℃.
The components of the invention have the following functions:
burdock root: the burdock root mainly contains chemical components such as sulfur alkynes, polyacetylenes, polyphenols, volatile oil, inulin, amino acid and the like; the pharmacological activity mainly comprises antibiosis, mutation resistance, cancer prevention, oxidation resistance, fatigue resistance, blood sugar reduction, blood fat reduction, immunity regulation and the like; the main treatment is as follows: dispel wind-heat, eliminate swelling and toxin. It is indicated for wind-toxin swelling of face, dizziness, swollen heat in throat, toothache, cough, diabetes, abscess, sore, scabies. The burdock root has a certain effect of tonifying yang and kidney, the burdock root contains a component called arctiin, can enhance energy and play a good role in kidney deficiency, the contained component can effectively improve the function of kidney, namely tonifying kidney in traditional Chinese medicine, the component can promote the secretion of hormone, and as mentioned above, the burdock is an excellent health food for both men and women, can make the body increasingly healthy, and has remarkable effects of tonifying kidney and yang.
Ginseng powder: the ginseng powder is artificially planted ginseng, and the main components of the ginseng powder are ginseng soap, ginseng active element, a small amount of volatile oil, various amino acids and peptides, glucose, fructose, pectin, vitamin B1, vitamin B2, nicotinic acid, pantothenic acid and the like. The nutrient components of ginseng can be slowly absorbed by skin, has no any adverse stimulation to skin, can expand the capillary vessels of skin, promote the blood circulation of skin, enhance the nutrition of skin, prevent the skin from dehydration, hardening and wrinkling, thereby enhancing the elasticity of skin, enabling cells to be regenerated, and has the effect of beautifying, protecting the skin from smoothness and moistening, preventing premature senility. The ginseng powder is the powder made by grinding ginseng, and the pharmacological activity mainly has the effects of greatly invigorating primordial qi, tonifying five internal organs, benefiting primordial qi, promoting blood circulation, promoting the production of body fluid to quench thirst, calming the nerves, promoting intelligence and the like; it can be used for treating asthenia due to strain, anorexia, fatigue, regurgitation, constipation, asthenia, cough, dyspnea, spontaneous perspiration, palpitation, amnesia, vertigo, headache, sexual impotence, frequent micturition, diabetes, metrorrhagia, infantile pavor, asthenia, and deficiency of both qi and blood. Especially, when rescuing shock patients, the ginseng can play an important role, and also has a certain treatment effect on diabetes, arrhythmia, cerebrovascular disease, hyperlipidemia and dyspepsia, and also has an effect on cancer patients because the ginseng can improve the immunity.
Oyster peptide: every hundred grams of oyster, zinc element is up to 13.2 milligrams, male can meet the demand of body to zinc to eat one every day; the oyster extract has obvious platelet aggregation inhibiting effect, can reduce the blood fat of hyperlipemia patients and the content of TXA2 in blood, is beneficial to the secretion and utilization of insulin, can enhance the sensitivity of malignant tumor cells to radioactive rays, and has inhibiting effect on the growth of malignant tumor cells; the taurine contained in the oyster has obvious functions of protecting liver and benefiting gallbladder, which is also a good medicine for preventing and treating liver and gallbladder juice stasis during pregnancy; rich trace elements and glycogen are contained, and the health care product is beneficial to promoting the growth and development of fetuses, correcting anemia of pregnant women and restoring physical strength of the pregnant women; oyster is also the best food for supplementing calcium, and contains rich phosphorus, and the calcium is absorbed by human body with the help of phosphorus, so that the oyster is beneficial to the absorption of calcium.
Fine yellow powder: invigorating qi, nourishing yin, invigorating spleen, moistening lung, invigorating kidney, and resisting anoxia, fatigue and aging; can enhance immunity and metabolism; has effects in lowering blood sugar and tonifying heart.
Licorice powder: glycyrrhiza uralensis belongs to tonifying medicines of traditional Chinese medicines and is a perennial herb of leguminosae. Its root and stem are sweet and neutral in nature, enter heart, lung, spleen and stomach meridians, and have the main effects of benefiting qi, invigorating spleen, clearing away heat and toxic material, expelling phlegm, arresting cough, relieving spasm, relieving pain, and moderating drug property. Modern pharmacological research shows that the licorice contains glycyrrhizin, licorice flavonoid, glycyrrhizin, glycyphyllin, aspartamide, mannitol, etc. Licoflavone has multiple effects in cosmetic. The liquorice is a good cosmetic additive, has good effects in inhibiting formation of cell melanin, inhibiting activity of tyrosinase and resisting oxidation, can be used in cosmetics, and has whitening and anti-aging effects.
Sea cucumber peptide: the sea cucumber peptide is refined by applying an international advanced peptide molecule biological enzymolysis technology, completely reserves the specific nutrient components of sea cucumber, converts macromolecular protein into micromolecular active peptide which is easier to absorb and has stronger function, and is more comprehensive to absorb than the traditional sea cucumber product.
Silkworm pupa peptide: silkworm pupa peptide can increase the production of EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid), and clinical pharmacology has proved that: EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) can obviously reduce lipid substances such as total cholesterol, low density lipoprotein and triglyceride in blood, resist peroxidation of the lipid substances and protect blood vessel walls; can also inhibit platelet aggregation and reduce blood viscosity; can be used for preventing and treating cerebral arteriosclerosis after long-term administration. Meanwhile, the specific component can also reduce the level of lysophosphatidic acid (the increase of the level of lysophosphatidic acid indicates that platelets are activated to cause the formation of platelet thrombus), and effectively prevent the formation of the platelet thrombus, thereby reducing the occurrence of cerebral apoplexy such as cerebral thrombosis and the like.
Litchi extract: the litchi extract has effects of caring skin, supplementing physical strength, cleaning blood, strengthening skeleton, preventing scurvy, enhancing immunity, and resisting cancer, and has high nutritive value.
Chinese yam: can be used for preventing cardiovascular diseases. In winter, the indoor temperature difference is large, the temperature is generally low, the Chinese yam is one of the peak seasons for cardiovascular diseases, contains a large amount of mucin, vitamins and trace elements, can effectively prevent the precipitation of blood fat on the vascular wall, prevents cardiovascular diseases, has the effects of reducing blood pressure and stabilizing mind, and is very suitable for being eaten in winter. Has effects in invigorating spleen, benefiting stomach, and promoting digestion. The exercise amount in winter can be unconsciously reduced, the frequency of metabolism is reduced due to the reduction of the temperature, and the frequency of eating hot pots in winter is increased, so that the probability of suffering from gastrointestinal diseases is increased. The yam contains amylase, polyphenol oxidase and other substances, is beneficial to the digestion and absorption functions of the spleen and the stomach, and is a medicine and food dual-purpose product for tonifying the spleen and the stomach. It is suitable for patients with spleen yang deficiency or stomach yin deficiency. Clinically, it is often combined with gastrointestinal drinking to treat weakness of spleen and stomach, poor appetite, tiredness, diarrhea, etc., so that yam is not added in cooking soup and eating chafing dish in winter. Can benefit lung and relieve cough. The dioscorea opposita contains saponin and mucus, and the two components have the effects of lubricating and moistening, so that the dioscorea opposita can tonify lung qi, nourish lung yin, and treat symptoms such as lung deficiency, phlegm cough, chronic cough and the like.
Extract of fructus Lycii: the record of Shen nong Ben Cao Jing: medlar is bitter and cold in flavor, mainly causes pathogenic factors in five interior, causes heat in middle and causes diabetes, strengthens bones and muscles after long-term administration, and is light and not old. Compendium (compendium): nourishing kidney, moistening lung, improving eyesight. The lycium barbarum polysaccharide extracted from the lycium barbarum has the function of enhancing the immune function, can improve the state of low immune function and prolong the life cycle. Fructus Lycii can regulate immunity, so it is beneficial for the elderly to prevent and treat tumor. The old people take the medlar extract, the sleep and the appetite are obviously improved, the physical strength is enhanced, the cold frequency is reduced, and the medlar has the functions of reducing serum cholesterol and increasing phospholipid. Fructus Lycii is effective in invigorating kidney, nourishing yin and blood, improving eyesight, treating diabetes, hyperlipidemia, abnormal liver function, gastritis, and regulating immunity, and preventing and treating tumor; and reducing the phenomenon of leucopenia caused by chemotherapy.
The leek extract: contains volatile oil, sulfide, protein, fat, saccharide, vitamin B, vitamin C, etc., has warm property and pungent taste, and has effects of invigorating kidney and tonifying yang, so it can be used for treating sexual impotence, spermatorrhea, premature ejaculation, etc.; liver-benefiting and stomach-invigorating, which contains volatile essential oil and sulfide as special components, emits a unique spicy smell, is helpful for regulating liver qi, stimulating appetite and enhancing digestion function; promoting qi and blood circulation, the pungent smell has the functions of removing blood stasis and activating blood circulation, and promoting qi circulation and removing food stagnation, and is suitable for treating traumatic injury, regurgitation, enteritis, hematemesis, chest pain and other diseases; intestine moistening and constipation relieving, contains abundant vitamins and crude fiber, and has effects of promoting gastrointestinal motility, treating constipation, and preventing intestinal cancer.
Mulberry extract: the mulberry is a natural plant containing antioxidant active substances, and the mulberry extract has important values and effects in reducing blood fat and preventing arteriosclerosis.
The dendrobium officinale extract: the dendrobium officinale is a special plant with ornamental value and medicinal value, and has the following main effects: the human body immunity function is increased: the dendrobium officinale contains rich polysaccharide substances and has the function of enhancing the immunologic function, and the modern pharmacological research shows that the dendrobium officinale can improve the stress capability of a human body and has good functions of resisting fatigue and resisting anoxia; and (3) digestion promotion: the dendrobium officinale is a medicament for benefiting stomach and promoting fluid production, is a commonly used medicament for treating epigastric pain and epigastric distending pain, and is proved by experiments of modern medicine, the dendrobium officinale has a good inhibiting effect on common pathogenic bacteria helicobacter pylori in spleen and stomach diseases, is beneficial to treating helicobacter pylori positive diseases such as atrophic gastritis, superficial gastritis and duodenal ulcer, and meanwhile, oral dendrobium officinale decoction can promote gastric secretion, enhance the emptying capacity of the stomach and help digestion; protecting liver and benefiting gallbladder: according to doctors of the past generations, dendrobium officinale has the effect of nourishing liver yin, is a medicament for treating various liver and gallbladder diseases, and can be used for treating liver and gallbladder diseases such as hepatitis, cholecystitis, gallstone and the like; and (3) wind and moisture resistance: when people enter middle-aged years, yin essence begins to weaken, the functions of muscles and bones are gradually reduced, and the dendrobium officinale can help nourish yin fluid and lubricate joints, so that the effects of strengthening muscles and bones, smoothing joints and enhancing rheumatism resistance are achieved; the dendrobium officinale can help to reduce or control blood sugar and blood fat, can nourish yin, clear heat and moisten dryness, and is a special medicine for treating diabetes since ancient times, and clinical researches show that the dendrobium officinale can not only enhance the activity of insulin, but also obviously reduce the blood sugar level and enable the blood sugar to tend to be normal; promoting circulation, dilating blood vessel, and reducing blood cholesterol and triglyceride; the dendrobium officinale has the effects of protecting eyesight, nourishing yin and eyes, is taken as a good item for protecting eyes by doctors of all ages, and has obvious effects on preventing and treating senile cataract and protecting children eyesight through modern pharmacological research.
Fructo-oligosaccharide: the fructo-oligosaccharide is a water-soluble dietary fiber, can reduce serum cholesterol and improve lipid metabolism after being taken for a long time, and has the following effects: the low heat value, because the fructo-oligosaccharide can not be directly digested and absorbed by human body, and can only be absorbed and utilized by intestinal bacteria, the heat value is low, the obesity can not be caused, and the weight-reducing effect can be indirectly realized. It is also a good sweetener for diabetic patients. It can not be used by oral bacteria, and thus has dental caries preventing effect. Has the function of proliferating beneficial bacteria in the intestinal tract. The fructo-oligosaccharide has selective proliferation effect on beneficial bacteria such as Bifidobacterium, Lactobacillus, etc. in intestinal tract, so that beneficial bacteria have advantages in intestinal tract, inhibit growth of harmful bacteria, reduce formation of toxic substances (such as endotoxin, ammonia, etc.), and protect intestinal mucosa cell and liver, thereby preventing pathological intestinal cancer and enhancing immunity. Can reduce the content of cholesterol and triglyceride in serum. Promoting nutrient absorption, especially calcium absorption. Can be used for preventing and treating diarrhea and constipation.
L-arginine: arginine is an essential amino acid for maintaining the growth and development of infants. It is an intermediate metabolite of the ornithine cycle that promotes the conversion of ammonia to urea, thereby reducing blood ammonia content. It is also the main component of sperm protein, and has the functions of promoting spermatogenesis and providing sperm movement energy. In addition, arginine, administered intravenously, stimulates the release of growth hormone from the pituitary gland and can be used for pituitary function tests.
Glycine: can be used as nutritional supplement. It is mainly used for flavoring, and can also be used for medicine.
Glutamic acid: can be used as salt substitute, nutritional supplement, and flavoring agent, and can also be used in medicine.
L-threonine: threonine is an important nutrition enhancer, can strengthen grains, cakes and dairy products, and has the effects of recovering human fatigue and promoting growth and development like tryptophan. In medicine, threonine contains hydroxyl in the structure, has a water-holding effect on human skin, is combined with oligosaccharide chains, plays an important role in protecting cell membranes, and can promote phospholipid synthesis and fatty acid oxidation in vivo.
Beta-alanine: is mainly used for synthesizing pantothenic acid, calcium pantothenate, carnosine, pamidronate sodium, balsalazide and the like, and is widely applied in the fields of medicines, feeds, foods and the like.
Compared with the prior art, the burdock chewable tablet is prepared by taking burdock root as a main raw material, is rich in ginseng powder, oyster peptide, rhizoma polygonati powder, licorice powder, sea cucumber peptide, silkworm chrysalis peptide, lychee extract, Chinese yam, medlar extract, leek extract, mulberry extract, dendrobium officinale extract, fructo-oligosaccharide, L-arginine, glycine, glutamic acid, L-threonine, beta-alanine and vitamins; according to the invention, a modern low-temperature freezing technology is adopted, frozen burdock roots are subjected to cleaning, peeling, slicing, color protection, enzyme deactivation and cooling, and then mixed solution of fructo-oligosaccharide, isomaltooligosaccharide and maltitol is added, so that the burdock slices fully absorb litchi extract, medlar extract, leek extract, mulberry extract, dendrobium officinale extract and other raw materials to fill gaps of the burdock, the nutrition components of the burdock slices are higher, the absorptivity of the burdock is greatly increased, bioactive components are retained, the bioavailability is improved, the raw materials are natural, the prepared chewable tablets are good in taste, can be eaten by a large number of people for a long time, and can provide various nutrient substances lacking in human bodies.
Detailed Description
The present invention is further described below.
The raw materials used in the examples are all conventional commercial products, and the equipment used is conventional equipment.
Example 1
The formula of the health-preserving burdock chewable tablet is prepared from the following raw materials in parts by mass: 30 parts of burdock root, 10 parts of ginseng powder, 5 parts of oyster peptide, 5 parts of fine yellow powder, 4 parts of licorice powder, 2 parts of sea cucumber peptide, 2 parts of silkworm chrysalis peptide, 2 parts of litchi extract, 3 parts of Chinese yam, 2 parts of wolfberry extract, 2 parts of leek extract, 2 parts of mulberry extract, 2 parts of dendrobium officinale extract, 2 parts of fructo-oligosaccharide, 2 parts of isomalto-oligosaccharide, 2 parts of maltitol, 1 part of L-arginine, 1 part of glycine, 1 part of glutamic acid, 1 part of L-threonine, 1 part of beta-alanine and 2 parts of vitamin.
A preparation method of a health-preserving burdock chewable tablet formula comprises the following steps:
s1, putting the burdock roots in a low-temperature refrigeration house for storage for 3 months before use for fermentation treatment; converting starch in the burdock root into a saccharide substance;
s2, selecting: removing rotten and atrophic burdock roots;
s3, cleaning: washing the burdock roots with clear water;
s4, peeling: peeling burdock root;
s5, slicing and color protection: cutting burdock root into slices with thickness of 2.5mm on a slicer, and protecting color with 3 ‰ citric acid color protecting liquid, wherein the color protecting liquid can cover burdock slices as standard; the citric acid is properly supplemented along with the increase of the water amount in the pool because the slicing machine needs water flow assistance);
s6, deactivating enzyme and cooling: firstly, adding 3 per mill of citric acid into a water-removing pool, removing the water of the burdock slices after color protection for 2min by using clear water at the temperature of 100 ℃, softening fibers and converting partial starch in the burdock slices into alpha by using a deactivated enzyme system, and quickly cooling in a compound color-protecting liquid for 30min after water removal;
s7, draining, and picking: draining the cooled burdock slices, pouring the cooled burdock slices on a selecting table, and selecting large, irregular and foreign matters;
s8, weighing ginseng powder, oyster peptide, rhizoma polygonati powder, licorice powder, sea cucumber peptide, silkworm pupa peptide, litchi extract, Chinese yam, wolfberry fruit extract, leek extract, mulberry extract, dendrobium officinale extract, L-arginine, glycine, glutamic acid, L-threonine, beta-alanine, vitamins, additives and the burdock slices in the step S7 according to the proportion respectively, soaking the burdock slices in a mixed solution of fructo-oligosaccharide, isomaltooligosaccharide and maltitol for more than 48 hours to enable the burdock slices to fully absorb the litchi extract, wolfberry fruit extract, leek extract, mulberry extract, dendrobium officinale extract and other raw materials to fill burdock gaps, so that the burdock slices have higher nutritional ingredients, and then baking the burdock slices at 80 ℃ to enable the water to be volatilized without sand feedback and sugar feedback;
s9, granulating and tabletting: after the mixture in the S8 is sieved by a 20-mesh sieve, drying and sieving particles to ensure that the water content of the particles is less than 5%; pressing the granules into tablets, and packaging the tablets after pasteurization to obtain the finished burdock agglomerant tablets.
And the step S4, wherein manual peeling or mechanical peeling is adopted for peeling.
In order to ensure that the water-removing is complete and not rotten, the weight of the burdock slices in the water-removing pool is not too large, and is preferably 0.8 kg.
The low-temperature environment in step S1 is 2 ℃.
Example 2
The formula of the health-preserving burdock chewable tablet is prepared from the following raw materials in parts by mass: 35 parts of burdock root, 15 parts of ginseng powder, 7.5 parts of oyster peptide, 7.5 parts of sealwort powder, 5 parts of licorice powder, 3 parts of sea cucumber peptide, 3 parts of silkworm chrysalis peptide, 2.5 parts of litchi extract, 4 parts of Chinese yam, 2.5 parts of medlar extract, 2.5 parts of leek extract, 2.5 parts of mulberry extract, 2.5 parts of dendrobium officinale extract, 2.5 parts of fructo-oligosaccharide, 2.5 parts of isomaltooligosaccharide, 2.5 parts of maltitol, 1.5 parts of L-arginine, 1.5 parts of glycine, 1.5 parts of glutamic acid, 1.5 parts of L-threonine, 1.5 parts of beta-alanine and 2.5 parts of vitamin.
A preparation method of a health-preserving burdock chewable tablet formula comprises the following steps:
s1, putting the burdock roots in a low-temperature refrigeration house for storage for 4.5 months before use for fermentation treatment; converting starch in the burdock root into a saccharide substance;
s2, selecting: removing rotten and atrophic burdock roots;
s3, cleaning: washing the burdock roots with clear water;
s4, peeling: peeling burdock root;
s5, slicing and color protection: cutting burdock root into slices with thickness of 2.75mm on a slicer, and protecting color with 3 ‰ citric acid color protecting liquid, wherein the color protecting liquid can cover burdock slices as standard; as the slicing machine needs water flow aid, citric acid needs to be properly supplemented along with the increase of the water amount in the pool;
s6, deactivating enzyme and cooling: firstly, adding 3 per mill of citric acid into a water-removing pool, removing the water of the burdock slices after color protection for 2.5min by using clear water at the temperature of 100 ℃, so as to passivate an enzyme system, soften the fiber and convert part of starch in the burdock slices into alpha, and quickly cooling in a compound color-protecting liquid for 30min after water removal;
s7, draining, and picking: draining the cooled burdock slices, pouring the cooled burdock slices on a selecting table, and selecting large, irregular and foreign matters;
s8, weighing ginseng powder, oyster peptide, rhizoma polygonati powder, licorice powder, sea cucumber peptide, silkworm pupa peptide, litchi extract, Chinese yam, wolfberry extract, leek extract, mulberry extract, dendrobium officinale extract, L-arginine, glycine, glutamic acid, L-threonine, beta-alanine, vitamins, additives and the burdock slices in the step S7 according to the proportion, soaking the burdock slices in a mixed solution of fructo-oligosaccharide, isomaltooligosaccharide and maltitol for more than 48 hours to ensure that the burdock slices fully absorb the litchi extract, wolfberry extract, leek extract, mulberry extract, dendrobium officinale extract and other raw materials to fill burdock gaps, so that the burdock slices have higher nutritional ingredients, and then baking the burdock slices at 80 ℃ to volatilize water without sand reaction and sugar reaction;
s9, granulating and tabletting: after the mixture in the S8 is sieved by a 20-mesh sieve, drying and sieving particles to ensure that the water content of the particles is less than 5%; pressing the granules into tablets, and packaging the tablets after pasteurization to obtain the finished burdock agglomerant tablets.
And the step S4, wherein manual peeling or mechanical peeling is adopted for peeling.
In order to ensure that the water-removing is complete and not rotten, the weight of the burdock slices in the water-removing pool is not too large, and is preferably 1 kg.
The low temperature environment in step S1 is 5 ℃.
Example 3
The formula of the health-preserving burdock chewable tablet is prepared from the following raw materials in parts by mass: 40 parts of burdock root, 20 parts of ginseng powder, 10 parts of oyster peptide, 10 parts of fine yellow powder, 6 parts of licorice powder, 4 parts of sea cucumber peptide, 4 parts of silkworm chrysalis peptide, 3 parts of litchi extract, 5 parts of Chinese yam, 3 parts of wolfberry extract, 3 parts of leek extract, 3 parts of mulberry extract, 3 parts of dendrobium officinale extract, 3 parts of fructo-oligosaccharide, 3 parts of isomalto-oligosaccharide, 3 parts of maltitol, 2 parts of L-arginine, 2 parts of glycine, 2 parts of glutamic acid, 2 parts of L-threonine, 2 parts of beta-alanine and 3 parts of vitamin.
A preparation method of a health-preserving burdock chewable tablet formula comprises the following steps:
s1, putting the burdock roots in a low-temperature refrigeration house for storage for 6 months before use for fermentation treatment; converting starch in the burdock root into a saccharide substance;
s2, selecting: removing rotten and atrophic burdock roots;
s3, cleaning: washing the burdock roots with clear water;
s4, peeling: peeling burdock root;
s5, slicing and color protection: cutting burdock root into slices with thickness of 3mm on a slicer, and protecting color with 3 ‰ citric acid color protecting liquid, wherein the color protecting liquid can cover burdock slice as standard; as the slicing machine needs water flow aid, citric acid needs to be properly supplemented along with the increase of the water amount in the pool;
s6, deactivating enzyme and cooling: firstly, adding 3 per mill of citric acid into a water-removing pool, removing the water of the burdock slices after color protection for 3min by using clear water at the temperature of 100 ℃, softening fibers and converting partial starch in the burdock slices into alpha by using a deactivated enzyme system, and quickly cooling in a compound color-protecting liquid for 30min after water removal;
s7, draining, and picking: draining the cooled burdock slices, pouring the cooled burdock slices on a selecting table, and selecting large, irregular and foreign matters;
s8, weighing ginseng powder, oyster peptide, rhizoma polygonati powder, licorice powder, sea cucumber peptide, silkworm pupa peptide, litchi extract, Chinese yam, wolfberry extract, leek extract, mulberry extract, dendrobium officinale extract, L-arginine, glycine, glutamic acid, L-threonine, beta-alanine, vitamins, additives and the burdock slices in the step S7 according to the proportion, soaking the burdock slices in a mixed solution of fructo-oligosaccharide, isomaltooligosaccharide and maltitol for more than 48 hours to ensure that the burdock slices fully absorb the litchi extract, wolfberry extract, leek extract, mulberry extract, dendrobium officinale extract and other raw materials to fill burdock gaps, so that the burdock slices have higher nutritional ingredients, and then baking the burdock slices at 80 ℃ to volatilize water without sand reaction and sugar reaction;
s9, granulating and tabletting: after the mixture in the S8 is sieved by a 20-mesh sieve, drying and sieving particles to ensure that the water content of the particles is less than 5%; pressing the granules into tablets, and packaging the tablets after pasteurization to obtain the finished burdock agglomerant tablets.
And the step S4, wherein manual peeling or mechanical peeling is adopted for peeling.
In order to ensure that the water-removing is thorough and not rotten, the weight of the burdock slices in the water-removing pool is not too large, and is preferably 1.2 kg.
The low temperature environment in step S1 is 8 ℃.
The burdock chewable tablet of the invention invites a plurality of tasters to taste, and the reaction effect is good.
Claims (7)
1. The formula of the health-preserving burdock chewable tablet is characterized in that the chewable tablet is prepared from the following raw materials in parts by mass: 30-40 parts of burdock root, 10-20 parts of ginseng powder, 5-10 parts of oyster peptide, 5-10 parts of rhizoma polygonati powder, 4-6 parts of licorice powder, 2-4 parts of sea cucumber peptide, 2-4 parts of silkworm chrysalis peptide, 2-3 parts of litchi extract, 3-5 parts of Chinese yam, 2-3 parts of wolfberry extract, 2-3 parts of leek extract, 2-3 parts of mulberry extract, 2-3 parts of dendrobium officinale extract, 2-3 parts of fructo-oligosaccharide, 2-3 parts of isomalto-oligosaccharide, 2-3 parts of maltitol, 1-2 parts of L-arginine, 1-2 parts of glycine, 1-2 parts of glutamic acid, 1-2 parts of L-threonine, 1-2 parts of beta-alanine and 2-3 parts of vitamin.
2. The formula of the health-preserving burdock chewable tablet according to claim 1 is characterized in that the chewable tablet is prepared from the following raw materials in parts by mass: 35 parts of burdock root, 15 parts of ginseng powder, 7.5 parts of oyster peptide, 7.5 parts of sealwort powder, 5 parts of licorice powder, 3 parts of sea cucumber peptide, 3 parts of silkworm chrysalis peptide, 2.5 parts of litchi extract, 4 parts of Chinese yam, 2.5 parts of medlar extract, 2.5 parts of leek extract, 2.5 parts of mulberry extract, 2.5 parts of dendrobium officinale extract, 2.5 parts of fructo-oligosaccharide, 2.5 parts of isomaltooligosaccharide, 2.5 parts of maltitol, 1.5 parts of L-arginine, 1.5 parts of glycine, 1.5 parts of glutamic acid, 1.5 parts of L-threonine, 1.5 parts of beta-alanine and 2.5 parts of vitamin.
3. The health burdock chewable tablet formulation of claim 1 or 2, wherein the vitamin is vitamin B, vitamin C or vitamin E.
4. The preparation method of the health-preserving burdock chewable tablet formula is characterized by comprising the following steps of:
s1, putting the burdock roots in a low-temperature refrigeration house for storage for 3-6 months before use for fermentation treatment;
s2, selecting: removing rotten and atrophic burdock roots;
s3, cleaning: washing the burdock roots with clear water;
s4, peeling: peeling burdock root;
s5, slicing and color protection: cutting the burdock roots into slices with the thickness of 2.5-3 mm on a slicing machine, and protecting the color by using 3 per mill of citric acid color protection liquid, wherein the color protection liquid can cover the burdock slices as a standard;
s6, deactivating enzyme and cooling: firstly, adding 3 per mill of citric acid into a water-removing pool, removing the water of the color-protected burdock slices for 2-3 min at the temperature of 100 ℃ by using clear water, and quickly cooling the water-removed burdock slices in a compound color-protecting liquid for 30 min;
s7, draining, and picking: draining the cooled burdock slices, pouring the cooled burdock slices on a selecting table, and selecting large, irregular and foreign matters;
s8, weighing ginseng powder, oyster peptide, rhizoma polygonati powder, licorice powder, sea cucumber peptide, silkworm chrysalis peptide, litchi extract, Chinese yam, wolfberry extract, leek extract, mulberry extract, dendrobium officinale extract, L-arginine, glycine, glutamic acid, L-threonine, beta-alanine, vitamins, additives and the burdock slices in the step S7 according to the proportion respectively, soaking the burdock slices in fructo-oligosaccharide, isomalto-oligosaccharide and maltitol for more than 48 hours, and then baking the burdock slices at 80 ℃ to volatilize water without sand reaction or sugar reaction;
s9, granulating and tabletting: after the mixture in the S8 is sieved by a 20-mesh sieve, drying and sieving particles to ensure that the water content of the particles is less than 5%; pressing the granules into tablets, and packaging the tablets after pasteurization to obtain the finished burdock agglomerant tablets.
5. The method for preparing the health burdock chewable tablet formulation according to claim 4, wherein the peeling in the step S4 is manually peeled or mechanically peeled.
6. The preparation method of the health burdock chewable tablet formulation according to claim 4, wherein the weight of the burdock slices in the water-removing pool of the step S6 is 0.8-1.2 kg.
7. The preparation method of the health burdock chewable tablet formulation according to claim 4, wherein the low temperature environment in the step S1 is 2-8 ℃.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911036751.8A CN110693931A (en) | 2019-10-29 | 2019-10-29 | Formula and preparation method of health-preserving burdock chewable tablet |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911036751.8A CN110693931A (en) | 2019-10-29 | 2019-10-29 | Formula and preparation method of health-preserving burdock chewable tablet |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110693931A true CN110693931A (en) | 2020-01-17 |
Family
ID=69202568
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201911036751.8A Pending CN110693931A (en) | 2019-10-29 | 2019-10-29 | Formula and preparation method of health-preserving burdock chewable tablet |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110693931A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111110783A (en) * | 2020-02-28 | 2020-05-08 | 烟台优达生物技术开发有限公司 | Formula of male yang-strengthening kidney-tonifying product |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103783429A (en) * | 2014-01-16 | 2014-05-14 | 天益食品(徐州)有限公司 | Burdock crisp chips |
CN103783369A (en) * | 2014-01-22 | 2014-05-14 | 天益食品(徐州)有限公司 | Burdock chewable tablet and preparation method thereof |
CN105876693A (en) * | 2016-04-28 | 2016-08-24 | 马鞍山菌菌食品科技有限公司 | Fructus Arctii chewable tablet with effects of clearing away heat and maintaining health and preparation method of Fructus Arctii chewable tablet |
CN106943586A (en) * | 2017-03-31 | 2017-07-14 | 山东岐伯堂生物科技有限公司 | A kind of male health-care yang-invigorating formulation production method |
-
2019
- 2019-10-29 CN CN201911036751.8A patent/CN110693931A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103783429A (en) * | 2014-01-16 | 2014-05-14 | 天益食品(徐州)有限公司 | Burdock crisp chips |
CN103783369A (en) * | 2014-01-22 | 2014-05-14 | 天益食品(徐州)有限公司 | Burdock chewable tablet and preparation method thereof |
CN105876693A (en) * | 2016-04-28 | 2016-08-24 | 马鞍山菌菌食品科技有限公司 | Fructus Arctii chewable tablet with effects of clearing away heat and maintaining health and preparation method of Fructus Arctii chewable tablet |
CN106943586A (en) * | 2017-03-31 | 2017-07-14 | 山东岐伯堂生物科技有限公司 | A kind of male health-care yang-invigorating formulation production method |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111110783A (en) * | 2020-02-28 | 2020-05-08 | 烟台优达生物技术开发有限公司 | Formula of male yang-strengthening kidney-tonifying product |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102511869B (en) | Thickened red jujube ginger pulp | |
CN102138671A (en) | Formula and preparation method of ginseng health-care cake containing eight delicacies | |
CN109463696A (en) | A kind of winter health preserving soup product and preparation method thereof | |
CN105533574A (en) | Toxin removing and body slimming green plum fruit and production technology thereof | |
CN105105008A (en) | Diet noodles with weight losing function and preparation method thereof | |
CN105878812B (en) | Hangover alleviating beverage prepared from Camellia chrysantha and herba Dendrobii, and its preparation method | |
CN101406291B (en) | A herbal nutritious beverage and its preparation method | |
CN109170014A (en) | A kind of dendrobe health-care tea and preparation method thereof | |
CN102511876B (en) | Hawthorn red jujube thick syrup and production process thereof | |
CN110693931A (en) | Formula and preparation method of health-preserving burdock chewable tablet | |
CN103004991A (en) | Cactus yogurt and processing technique thereof | |
CN105851395A (en) | Astragalus membranaceus health tea and preparation method thereof | |
CN105077501A (en) | Weight-reducing drink for young women | |
CN102524868A (en) | Concentrated pulp containing red jujube, autumn pear and loquat | |
CN102524869A (en) | Concentrate of Chinese date, pear and medlar | |
CN104031805B (en) | Be in harmonious proportion health preserving wine and preparation method thereof a kind of autumn | |
CN113080347A (en) | Herbal beverage for improving digestive system of human body and preparation method thereof | |
CN102450328A (en) | Cactus yogurt and processing technology thereof | |
CN114748583A (en) | Traditional Chinese medicine liquor for nourishing and preserving health | |
KR20210041387A (en) | A natural tea removing the effect of hangover contained the extract material in arrowroot blossoms and Plantago ovata | |
KR20030014478A (en) | Manufacturing method of health enriched food used dehydrated a snake head and dehydrated marine products | |
CN110679935A (en) | Burdock and ginseng essence cream and preparation method thereof | |
CN108967757A (en) | A kind of thickened red jujube ginger pulp production technology | |
CN110584037A (en) | Food ginseng cream and preparation method thereof | |
CN109170052A (en) | A kind of dendrobium nobile stomach-nourishing health tea and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200117 |
|
RJ01 | Rejection of invention patent application after publication |